Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021
Stephanie Perniciaro, Mark van der Linden, Daniel M. Weinberger
Clinical Infectious Diseases (2022) Vol. 75, Iss. 7, pp. 1149-1153
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Community-acquired bacterial pneumonia in children: an update on antibiotic duration and immunization strategies
Edward Lyon, Liset Olarte
Current Opinion in Pediatrics (2024) Vol. 36, Iss. 2, pp. 144-149
Closed Access | Times Cited: 4
Changing epidemic patterns of infectious diseases during and after COVID-19 pandemic in Taiwan
Ping‐Ing Lee, Po‐Ren Hsueh, Jen-Hsiang Chuang, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 5, pp. 685-690
Open Access | Times Cited: 4
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
Maria Garcia Quesada, Meagan E. Peterson, Julia C. Bennett, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 4
The Pneumococcus–Respiratory Virus Connection—Unexpected Lessons From the COVID-19 Pandemic
Ron Dagan, Dana Danino, Daniel M. Weinberger
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2218966-e2218966
Open Access | Times Cited: 18
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6)
Paul T. Scott, Miwa Haranaka, Jung‐Hyun Choi, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 3
The pattern of childhood infections during and after the COVID-19 pandemic
Ulrikka Nygaard, Mette Holm, Helena Rabie, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 12, pp. 910-920
Closed Access | Times Cited: 3
Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2
Phoebe Williams, Annaleise R. Howard‐Jones, Coen Butters, et al.
The Pediatric Infectious Disease Journal (2023) Vol. 42, Iss. 9, pp. e341-e342
Open Access | Times Cited: 8
Unique Changes in the Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Unravel the Role of Respiratory Pathogens
Zein Assad, Zaba Valtuille, Alexis Rybak, et al.
CHEST Journal (2023) Vol. 165, Iss. 1, pp. 150-160
Open Access | Times Cited: 8
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
Timothy J. Chapman, Liset Olarte, Ghassan Dbaibo, et al.
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 137-147
Open Access | Times Cited: 7
Serotype Distribution and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae in COVID-19 Pandemic Era in Brazil
Samanta Cristine Grassi Almeida, Ana Paula Silva de Lemos, Ana Luiza Bierrenbach, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 401-401
Open Access | Times Cited: 2
Risk factors for symptoms of infection and the acquisition of pathogens among pilgrims at the Grand Magal of Touba, 2017–2021
Ndiaw Goumballa, Van Thuan Hoang, F Diouf, et al.
Travel Medicine and Infectious Disease (2022) Vol. 49, pp. 102418-102418
Open Access | Times Cited: 11
Age-Specific Resurgence in Invasive Pneumococcal Disease Incidence in the COVID-19 Pandemic Era and Its Association With Respiratory Virus and Pneumococcal Carriage Dynamics: A Time-Series Analysis
Alexis Rybak, Zein Assad, Corinne Lévy, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 855-859
Closed Access | Times Cited: 6
Increase in complicated upper respiratory tract infection in children during the 2022/2023 winter season—a post coronavirus disease 2019 effect?
Corona Metz, Andrea Schmid, Simon Veldhoen
Pediatric Radiology (2023)
Open Access | Times Cited: 5
Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis
Martín Brizuela, María Carolina Palermo, Tomás Alconada, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0297767-e0297767
Open Access | Times Cited: 1
The Global Burden of Community-Acquired Pneumonia, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, With a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy
Ronald Anderson, Charles Feldman
(2023)
Open Access | Times Cited: 4
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?
Ahmad Z. Al Meslamani
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1431-1434
Open Access | Times Cited: 3
Pneumococcal nasopharyngeal carriage in children under 5 years of age at an outpatient healthcare facility in Novi Sad, Serbia during the COVID-19 pandemic
Vladimir Petrović, Biljana Milosavljević, Milan Djilas, et al.
IJID Regions (2022) Vol. 4, pp. 88-96
Open Access | Times Cited: 5
Evaluation of Pediatric Invasive Bacterial Infections After the COVID-19 Pandemic
Yalçın Kara, Mahmut Can Kızıl, Gürkan Bozan, et al.
Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection (2024) Vol. 18, Iss. 2, pp. 12-19
Open Access
Letter from Japan
Shuhei Ideguchi, Kazuko Yamamoto
Respirology (2024) Vol. 29, Iss. 7, pp. 637-639
Open Access
Increased Incidence of Invasive Pneumococcal Disease in Hong Kong in 2023
Chrissy Wing Kwan Pang, Richard Vale, Kim Shijian Lao, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106178-106178
Closed Access
Anstieg invasiver Erkrankungen durch Streptokokken und komplizierte Pneumonien zum Ende der COVID-19-Pandemie
Tobias Ankermann, Johannes G. Liese
Kinder- und Jugendmedizin (2024) Vol. 24, Iss. 03, pp. 207-211
Closed Access
Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tāmaki Makaurau Auckland, Aotearoa New Zealand
Cameron Burton, Rachel Webb, Andrew Anglemyer, et al.
The Pediatric Infectious Disease Journal (2024)
Closed Access
Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-center, open-labeled, randomized trial
Courtney P. Olwagen, Alane Izu, Lara Van Der Merwe, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1011-1019
Open Access
Incidence of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort study
Jessica Weaver, Tianyan Hu, Bélène Podmore, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access
Optimising vaccination strategies to prevent invasive pneumococcal disease in the elderly. Which vaccine should come first?
H. Humphreys, Mary Corcoran
Clinical Microbiology and Infection (2024)
Closed Access

Scroll to top